Vertos Medical understands the value and importance of clinical evidence and has produced over a decade's worth of robust data validate the safety and effectiveness of the mild procedure.
20,000 Patients Treated
13 Clinical Studies
conducted at leading interventional pain institutions across the U.S.
20+ Peer-Reviewed Journal Articles
published to date
Level 1 Data Available
from CMS-approved MiDAS ENCORE Study7
Low Complication Rates:
- Clinically demonstrated equivalent safety profile to epidural steroid injections (ESI).7
- No major device-related complications reported in any clinical trial.2
- Adverse event rate <0.1% in more than 20,000 commercial cases.
Proven Long-term Efficacy
Functional Outcome Improvement – Cleveland Clinic Study at 1 Year1
Standing time increase:
From 8 min. to 56 min.
Walking distance increase:
From 246 ft. to 3,956 ft.
Completed Studies (11)
- MiDAS I: 78-patient, prospective, multi-center study.
- Cleveland Clinic Functional Outcomes Study: 40-patient, prospective, single-center study.
- Double-blind, prospective, randomized controlled study of epidural steroid injection vs. mild (Brown): 38-patient, single-center study.
- MiDAS II: 55-patient, prospective, multi-center study.
- mild case series (Wong): 17-patient, multi-center study.
- Surgery Intolerant Trial (Chopko): 14-patient, prospective, single-center study.
- mild procedure: Single-site prospective IRB study (Basu): 27-patient, prospective, single-center study.
- Prospective patient series (Deer et al): 46-patient, prospective, single-center study.
- Single-site series (Lingreen and Grider): 42-patient, retrospective, single-center study.
- mild Acute Safety Study: 90-patient, retrospective, multi-center study.
- MiDAS III: 138-patient, prospective, multi-center, randomized controlled study.
Ongoing Studies (2)
- mild Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study; now enrolling.
- MiDAS ENCORE: 302-patient, prospective, multi-center, randomized controlled clinical study; enrollment complete.